国家医疗委员会的仿制药政策：非专利药品政策：对注册药剂师和公共卫生是利还是弊？

{"title":"国家医疗委员会的仿制药政策：非专利药品政策：对注册药剂师和公共卫生是利还是弊？","authors":"Arjun Kumar Singhal, M. H. Siddiqui, Shalini Goldar, Naveen Kumar, Sonu Kumari Agrawal","doi":"10.4103/jme.jme_154_23","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":251651,"journal":{"name":"Journal of Medical Evidence","volume":"28 17","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-02-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"National Medical Commission’s Generic Drug Policy: A Boon or a Bane for RMPs and Public Health?\",\"authors\":\"Arjun Kumar Singhal, M. H. Siddiqui, Shalini Goldar, Naveen Kumar, Sonu Kumari Agrawal\",\"doi\":\"10.4103/jme.jme_154_23\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":251651,\"journal\":{\"name\":\"Journal of Medical Evidence\",\"volume\":\"28 17\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-02-23\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Medical Evidence\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.4103/jme.jme_154_23\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Medical Evidence","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4103/jme.jme_154_23","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}